# Cost Study of Linezolid Versus Vancomycin Among Previously Hospitalized Patients

> **NCT01363271** · — · COMPLETED · sponsor: **Pfizer** · enrollment: 7260 (actual)

## Conditions studied

- Complicated Skin and Structure Infection
- Nosocomial Pneumonia

## Interventions

- **DRUG:** Linezolid
- **DRUG:** Vancomycin
- **DRUG:** Linezolid
- **DRUG:** Vancomycin

## Key facts

- **NCT ID:** NCT01363271
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2012-05
- **Final completion:** 2012-05
- **Target enrollment:** 7260 (ACTUAL)
- **Last updated:** 2012-05-22

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01363271

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01363271, "Cost Study of Linezolid Versus Vancomycin Among Previously Hospitalized Patients". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01363271. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*